How Specific Signaling Pathways Like Wnt, Notch, and Hedgehog Regulate Cancer Stem Cells, and Potential Therapies Targeting These Pathways

Sameen Shahid; Syeda Hina Shah; Atiqa Rahman; Rahul Sagar Advani; Syeda Areeba Shiblee; Adeel-Ur-Rehman; Hassam Gul

doi:10.70749/ijbr.v3i4.1178

Authors

Sameen Shahid Center for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan.
Syeda Hina Shah Department of Biological Sciences, National University of Medical Sciences (NUMS), Rawalpindi, Pakistan.
Atiqa Rahman National University of Sciences and Technology (NUST) / Department of Biomedicine, Atta ur Rahman School of Applied Biosciences
Rahul Sagar Advani Newcastle University, Newcastle Upon Tyne, United Kingdom.
Syeda Areeba Shiblee Karachi Medical and Dental College, Karachi, Pakistan.
Adeel-Ur-Rehman Punjab institute of Neurosciences, Lahore, Pakistan.
Hassam Gul International Islamic University, Islamabad, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i4.1178

Keywords:

Cancer Stem Cells, Wnt Pathway, Notch Pathway, Hedgehog Pathway, Signaling Pathways, CSC Inhibition, Targeted Cancer Therapy

Abstract

This study investigates the roles of Wnt, Notch, and Hedgehog signaling pathways in the regulation of cancer stem cells (CSCs) and evaluates the effects of their inhibition on CSC properties, including self-renewal, proliferation, and resistance to conventional therapies. Established human cancer cell lines from colorectal, breast, and glioblastoma cancers were treated with specific inhibitors targeting these pathways. The cell lines were chosen based on their association with CSC-like populations and their responsiveness to signaling pathway inhibition. Flow cytometry was used to quantify the CSC population, while Western blotting analyzed the activation of β-catenin, NICD, and GLI proteins specific to Wnt, Notch, and Hedgehog pathways. Gene expression was assessed via quantitative PCR (qPCR) for stemness markers such as Oct4, Nanog, and Sox2. The MTT and clonogenic assays were employed to assess cell viability and self-renewal, respectively. One-way analysis of variance (ANOVA) revealed a significant difference in CSC populations and pathway activation following treatment with pathway inhibitors, with the Wnt inhibitor showing the most pronounced effect (p = 0.003). Post-hoc Tukey’s test confirmed significant differences between the control and treated groups, with the Wnt inhibitor reducing the CSC population most significantly. These findings underscore the potential of targeting the Wnt, Notch, and Hedgehog pathways for the development of novel cancer therapies aimed at eradicating CSCs and overcoming resistance to treatment. However, further studies are needed to explore combination therapies and clinical applicability.

Downloads

Download data is not yet available.

References

Takebe, N., et al., Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nature reviews Clinical oncology, 2015. 12(8): p. 445-464. https://doi.org/10.1038/nrclinonc.2015.61

Yang, L., et al., Targeting cancer stem cell pathways for cancer therapy. Signal transduction and targeted therapy, 2020. 5(1): p. 8. https://doi.org/10.1038/s41392-020-0110-5

Koury, J., L. Zhong, and J. Hao, Targeting signaling pathways in cancer stem cells for cancer treatment. Stem cells international, 2017. 2017(1): p. 2925869. https://doi.org/10.1155/2017/2925869

Justilien, V. and A.P. Fields, Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells. Clinical Cancer Research, 2015. 21(3): p. 505-513. https://doi.org/10.1158/1078-0432.ccr-14-0507

Kumar, V., et al., The role of Notch, Hedgehog, and Wnt signaling pathways in the resistance of tumors to anticancer therapies. Frontiers in cell and developmental biology, 2021. 9: p. 650772. https://doi.org/10.3389/fcell.2021.650772

Matsui, W.H., Cancer stem cell signaling pathways. Medicine, 2016. 95(1S): p. S8-S19. https://doi.org/10.1097/md.0000000000004765

Borlongan, M.C. and H. Wang, Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics. Frontiers in cell and developmental biology, 2023. 11: p. 1125174. https://doi.org/10.3389/fcell.2023.1125174

Curtin, J.C. and M.V. Lorenzi, Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget, 2010. 1(7): p. 563. https://doi.org/10.18632/oncotarget.191

Manni, W. and W. Min, Signaling pathways in the regulation of cancer stem cells and associated targeted therapy. MedComm, 2022. 3(4): p. e176. https://doi.org/10.1002/mco2.176

Taipale, J. and P.A. Beachy, The Hedgehog and Wnt signalling pathways in cancer. nature, 2001. 411(6835): p. 349-354. https://doi.org/10.1038/35077219

Valcourt, D., et al., Nanoparticles for manipulation of the developmental Wnt, Hedgehog, and Notch signaling pathways in cancer. Annals of biomedical engineering, 2020. 48(7): p. 1864-1884. https://doi.org/10.1007/s10439-019-02399-7

Karamboulas, C. and L. Ailles, Developmental signaling pathways in cancer stem cells of solid tumors. Biochimica et Biophysica Acta (BBA)-General Subjects, 2013. 1830(2): p. 2481-2495. https://doi.org/10.1016/j.bbagen.2012.11.008

Venkatesh, V., et al., Targeting Notch signalling pathway of cancer stem cells. Stem cell investigation, 2018. 5: p. 5. https://doi.org/10.21037/sci.2018.02.02

Samadani, A.A., et al., Cancer signaling pathways with a therapeutic approach: An overview in epigenetic regulations of cancer stem cells. Biomedicine & Pharmacotherapy, 2018. 108: p. 590-599. https://doi.org/10.1016/j.biopha.2018.09.048

Borah, A., et al., Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis, 2015. 4(11): p. e177-e177. https://doi.org/10.1038/oncsis.2015.35

Cochrane, C.R., et al., Hedgehog signaling in the maintenance of cancer stem cells. Cancers, 2015. 7(3): p. 1554-1585. https://doi.org/10.3390/cancers7030851

Clara, J.A., et al., Targeting signalling pathways and the immune microenvironment of cancer stem cells—a clinical update. Nature reviews clinical oncology, 2020. 17(4): p. 204-232. https://doi.org/10.1038/s41571-019-0293-2

Pires, B.R.B., et al., Targeting cellular signaling pathways in breast cancer stem cells and its implication for cancer treatment. Anticancer research, 2016. 36(11): p. 5681-5691. https://doi.org/10.21873/anticanres.11151

Rubin, L.L. and F.J. de Sauvage, Targeting the Hedgehog pathway in cancer. Nature reviews Drug discovery, 2006. 5(12): p. 1026-1033. https://doi.org/10.1038/nrd2086

Espinosa, J.M.S., Organizational culture and resilience as predictors of quality of work life among educators: A convergent design. Ignatian International Journal for Multidisciplinary Research, 2024. 2(1): p. 463-515.

Zardawi, S.J., et al., Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histology and histopathology, 2009.

Sarkar, F.H., et al., The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer and Metastasis Reviews, 2010. 29: p. 383-394. https://doi.org/10.1007/s10555-010-9233-4

Bolós, V., et al., Notch signalling in cancer stem cells. Clinical and Translational Oncology, 2009. 11: p. 11-19. https://doi.org/10.1007/s12094-009-0305-2

Bertrand, F.E., et al., Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell cycle, 2012. 11(23): p. 4344-4351. https://doi.org/10.4161/cc.22134

Harris, P.J., G. Speranza, and C. Dansky Ullmann, Targeting embryonic signaling pathways in cancer therapy. Expert opinion on therapeutic targets, 2012. 16(1): p. 131-145. https://doi.org/10.1517/14728222.2011.645808

Pannuti, A., et al., Targeting Notch to target cancer stem cells. Clinical cancer research, 2010. 16(12): p. 3141-3152. https://doi.org/10.1158/1078-0432.ccr-09-2823

Silva, V.R., et al., Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells. Cancer Communications, 2021. 41(12): p. 1275-1313. https://doi.org/10.1002/cac2.12235

Prokopi, M., C.A. Kousparou, and A.A. Epenetos, The secret role of microRNAs in cancer stem cell development and potential therapy: a Notch-pathway approach. Frontiers in oncology, 2015. 4: p. 389. https://doi.org/10.3389/fonc.2014.00389

Medina, V., et al., Hedgehog signalling as a target in cancer stem cells. Clinical and Translational Oncology, 2009. 11(4): p. 199-207. https://doi.org/10.1007/s12094-009-0341-y

Leon, G., et al., Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways. Pharmacology & therapeutics, 2016. 158: p. 71-90. https://doi.org/10.1016/j.pharmthera.2015.12.001

J Prud’homme, G., Cancer stem cells and novel targets for antitumor strategies. Current pharmaceutical design, 2012. 18(19): p. 2838-2849. https://doi.org/10.2174/138161212800626120

Dwivedi, A.R., et al., Targeting cancer stem cells pathways for the effective treatment of cancer. Current Drug Targets, 2020. 21(3): p. 258-278. https://doi.org/10.2174/1389450120666190821160730

García Campelo, M.R., et al., Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway. Clinical and Translational Oncology, 2011. 13: p. 77-83. https://doi.org/10.1007/s12094-011-0622-0

Blagodatski, A., D. Poteryaev, and V.L. Katanaev, Targeting the Wnt pathways for therapies. Molecular and cellular therapies, 2014. 2: p. 1-15. https://doi.org/10.1186/2052-8426-2-28

Oren, O. and B.D. Smith, Eliminating cancer stem cells by targeting embryonic signaling pathways. Stem cell reviews and reports, 2017. 13: p. 17-23. https://doi.org/10.1007/s12015-016-9691-3

Das, P.K., et al., Novel therapeutics against breast cancer stem cells by targeting surface markers and signaling pathways. Current stem cell research & therapy, 2019. 14(8): p. 669-682. https://doi.org/10.2174/1574888x14666190628104721

Abetov, D., et al., Novel small molecule inhibitors of cancer stem cell signaling pathways. Stem Cell Reviews and Reports, 2015. 11: p. 909-918. https://doi.org/10.1007/s12015-015-9612-x

Wend, P., et al. Wnt signaling in stem and cancer stem cells. in Seminars in cell & developmental biology. 2010. Elsevier. https://doi.org/10.1016/j.semcdb.2010.09.004

Song, K. and M. Farzaneh, Signaling pathways governing breast cancer stem cells behavior. Stem Cell Research & Therapy, 2021. 12(1): p. 245. https://doi.org/10.1186/s13287-021-02321-w

Ischenko, I., et al., Cancer stem cells: how can we target them? Current medicinal chemistry, 2008. 15(30): p. 3171-3184. https://doi.org/10.2174/092986708786848541

Iqbal, W., et al., Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis. Oncotarget, 2016. 7(46): p. 76337. https://doi.org/10.18632/oncotarget.10942

Giridharan, M., V. Rupani, and S. Banerjee, Signaling pathways and targeted therapies for stem cells in prostate cancer. ACS Pharmacology & Translational Science, 2022. 5(4): p. 193-206. https://doi.org/10.1021/acsptsci.2c00019

Dragu, D.L., et al., Therapies targeting cancer stem cells: Current trends and future challenges. World journal of stem cells, 2015. 7(9): p. 1185. https://doi.org/10.4252/wjsc.v7.i9.1185

Duchartre, Y., Y.-M. Kim, and M. Kahn, The Wnt signaling pathway in cancer. Critical reviews in oncology/hematology, 2016. 99: p. 141-149. https://doi.org/10.1016/j.critrevonc.2015.12.005

Lainez-González, D., J. Serrano-López, and J.M. Alonso-Domínguez, Understanding the hedgehog signaling pathway in acute myeloid leukemia stem cells: a necessary step toward a cure. Biology, 2021. 10(4): p. 255. https://doi.org/10.3390/biology10040255